Author | Eric Jonasch, MD | OncLive

Author | Eric Jonasch, MD

Articles

Dr. Jonasch on Modulating the Tumor Microenvironment in RCC

November 12, 2019

Video

Eric Jonasch, MD, discusses how to modulate the tumor microenvironment in renal cell carcinoma.

Dr. Jonasch on Utilizing the Tumor Microenvironment and Epigenetics as Biomarkers in RCC

September 19, 2019

Video

Eric Jonasch, MD, on how understanding features within the tumor microenvironment and mutated epigenetic modifying genes may provide insight on prognosis or treatment strategies in renal cell carcinoma.

Dr. Jonasch on Molecular Understanding of Clear Cell RCC

May 08, 2019

Video

Eric Jonasch, MD, professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the molecular understanding of clear cell renal cell carcinoma (RCC).

Dr. Jonasch on Single-Agent Pembrolizumab in Non-Clear Cell RCC

April 24, 2019

Video

Eric Jonasch, MD, professor of medicine, The University of Texas MD Anderson Cancer Center, discusses the use of single-agent pembrolizumab in the treatment of patients with metastatic non–clear cell renal cell carcinoma.

x